Previous hypertension, diabetes and renal insufficiency could alter plasma markers A multidisciplinary research team belonging to the Neurodegenerative Diseases Group of IDIVAL and the Cognitive Impairment Unit of the Neurology Service of the Marqués de Valdecilla University Hospital (HUMV) has conducted a study aimed at understanding how different physiological variables and previous diseases could influence […]
portal point to a high visibility of IDIVAL authors with more than 62,000 citations of articles published in the period 2018-2022. In this way, the Valdecilla brand exceeds 280,000 citations since its creation. Of note in the period 2018-22 are the citations of papers published in the areas of Immunology (1,383 citations), Pharmacology (1,307 citations) […]
It will allow Cantabria to implement pilot initiatives to promote healthier environments and reduce social inequalities The EU recently approved a proposal for a Joint Action for the prevention of Cancer and other Non Communicable Diseases (NCDs) with an amount of 75 million euros, which makes it a landmark initiative in public health. A […]
The results of the largest European prospective multicenter study on the surgical treatment of right colon cancer have been published. The MIRCAST study, an International multicenter project led for the whole of Europe from the IDIVAL Institute, was born in 2018 with the aim of evaluating the different ways of performing intestinal anastomosis after […]
Ankle fractures are the third most frequent cause of total fractures and generate functional alterations in the short and long term. Ankle fractures are the third most frequent cause of fractures in all ages. Surgical treatment and the period of immobilization generate important functional alterations in the short and long term such as pain, […]
The Instituto de Salud Carlos III (ISCIII) has opened the call for expressions of interest for the identification of people willing to collaborate with the ISCIII in the scientific evaluation of different biomedical and health research calls, such as those related to the Acción Estratégica en Salud (AES) or other external calls that the Institute […]
This new equipment expands the possibilities of identification and isolation of cellular and subcellular populations in a more precise way for use in biomedical research projects. IDIVAL already has a new CELL SEPARATOR (SORTER) in operation with greater functionalities, available both for IDIVAL researchers and external users. Its capacity to measure multiple cell parameters […]
These studies allow to have a better understanding of the seasonality of COVID-19 and to establish future vaccination strategies. Researchers from IDIVAL, Valdecilla Hospital and the University of Cantabria continue to analyze the influence of meteorological and geographical factors on the severity of COVID-19 in order to have a better understanding of the disease, its […]
The study, published in the prestigious scientific journal, opens the door to the development of new treatments Researchers from the Marqués de Valdecilla University Hospital (HUMV) and the Marqués de Valdecilla Research Institute (IDIVAL) are participating in an international genetic study published in the journal Nature that reveals new therapeutic targets that could facilitate the […]
Spinocerebellar ataxia type 15 (SCA15), characterized by alterations in the strength, speed and dexterity of movements, is the disease on which the genetic study that could help in its diagnosis and treatment in the future has focused. Neurologists and geneticists from different centers have participated in the research, including the researcher José Berciano from the […]
Biomedical research and innovation are only possible thanks to everyone’s collaboration. This is how we move forward in improving the health of patients and the wider community